Clinical Trial Update: Etanercept to Treat Wegener's Granulomatosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for etanercept in granulomatosis with polyangiitis (Wegener's granulomatosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Vasculitis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vasculitis, Wegener's Granulomatosis | Phase 2 | Status: COMPLETED